director of the Michigan Head Pain and Neurological Institute. Past President of the American Headache society, and clinical professor of Neurology.
Today an FDA advisory panel meets with lawmakers to hammer out voluntary best practices for doctors who prescribe opiates. The regulation of opioid drugs like Oxycontin has loosened in recent years, as patient advocates asked for powerful narcotic painkillers for end-of-life care and cancer treatments. But in loosening restrictions for such cases, the FDA opened a window for wider prescriptions — and for abuse.
The show is a co-production of WNYC Radio and Public Radio International, in collaboration with The BBC World Service, New York Times Radio and WGBH Boston.
Major funding provided by:
